NT5C2 Antibody (N-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P49902 |
---|---|
Clone Names | 101008044 |
Gene ID | 22978 |
---|---|
Other Names | Cytosolic purine 5'-nucleotidase, Cytosolic 5'-nucleotidase II, NT5C2, NT5B, NT5CP, PNT5 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | NT5C2 (HGNC:8022) |
---|---|
Synonyms | NT5B, NT5CP, PNT5 |
Function | Broad specificity cytosolic 5'-nucleotidase that catalyzes the dephosphorylation of 6-hydroxypurine nucleoside 5'-monophosphates (PubMed:1659319, PubMed:9371705, PubMed:10092873, PubMed:12907246). In addition, possesses a phosphotransferase activity by which it can transfer a phosphate from a donor nucleoside monophosphate to an acceptor nucleoside, preferably inosine, deoxyinosine and guanosine (PubMed:1659319, PubMed:9371705). Has the highest activities for IMP and GMP followed by dIMP, dGMP and XMP (PubMed:1659319, PubMed:9371705, PubMed:10092873, PubMed:12907246). Could also catalyze the transfer of phosphates from pyrimidine monophosphates but with lower efficiency (PubMed:1659319, PubMed:9371705). Through these activities regulates the purine nucleoside/nucleotide pools within the cell (PubMed:1659319, PubMed:9371705, PubMed:10092873, PubMed:12907246). |
Cellular Location | Cytoplasm, cytosol. |
Tissue Location | Widely expressed.. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Purine 5-prime-nucleotidase (EC 3.1.3.5) preferentiallyhydrolyzes inosine 5-prime-monophosphate (IMP) and other purinenucleotides, and is allosterically activated by various compounds,including ATP. The enzyme is exclusively located in the cytoplasmicmatrix of cells and may have a critical role in the maintenance ofa constant composition of intracellular purine/pyrimidinenucleotides in cooperation with other nucleotidases.[supplied byOMIM].
References
Niu, W., et al. Clin. Chim. Acta 411 (19-20), 1491-1495 (2010) :Yamauchi, T., et al. Biochem. Pharmacol. 77(12):1780-1786(2009)Newton-Cheh, C., et al. Nat. Genet. (2009) In press :Venkatesan, K., et al. Nat. Methods 6(1):83-90(2009)Jordheim, L.P., et al. Drug Metab. Dispos. 36(12):2419-2423(2008)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.